ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK’s Nucala approved to treat chronic rhinosinusitis with nasal polyps
August 02, 2021GlaxoSmithKline’s (GSK) interleukin-5 (IL-5) inhibitor has received approval from the US Food and Drug Administration (FDA) for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP). -
GSK launches late-stage study of long-acting antibody for severe asthma
March 18, 2021GlaxoSmithKline (GSK) has dosed the first patient in a Phase III trial investigating its long-acting anti-IL-5 monoclonal antibody for the treatment of severe eosinophilic asthma (SEA).
Pharma Sources Insight January 2025
